MS Bioworks

MS Bioworks is a leading proteomics service provider, leveraging advanced mass spectrometry technology to support research in biologics, drug discovery, and basic science. The company has established a strong track record, having processed over 70,000 samples and completed more than 12,000 projects for over 2,000 global customers. Its business model is built on providing expert, high-throughput analytical services with a focus on technical guidance and rapid turnaround. While privately held and not developing its own therapeutics, MS Bioworks occupies a critical niche as an enabling platform for the broader life sciences industry.

Advanced protein mass spectrometry and proteomics service platform featuring state-of-the-art LC-MS instrumentation (including Orbitrap Astral), automated sample preparation, high-resolution chromatography, and specialized bioinformatics pipelines for quantitative proteomics, PTM analysis, protein complex mapping, immunopeptidomics, and reactive cysteine profiling.

MS Bioworks competes in the specialized proteomics CRO space against other focused service providers (e.g., Poochon Scientific, Creative Proteomics) and the omics divisions of large, diversified CROs. Its differentiation is based on deep technical expertise, a broad portfolio of advanced services, a strong publication record, and a focus on client partnership and rapid turnaround.